Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
25. September 2024 16:05 ET
|
Telesis Bio
SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient...
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
10. September 2024 16:30 ET
|
Telesis Bio
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) (“Telesis” or the “Company”), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic...
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
07. August 2024 16:05 ET
|
Telesis Bio
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,...
Telesis Bio Reports First Quarter 2024 Financial Results
09. Mai 2024 16:05 ET
|
Telesis Bio
Telesis Bio Reports First Quarter 2024 Financial Results
Telesis Bio Announces Reverse Stock Split
06. Mai 2024 16:05 ET
|
Telesis Bio
Telesis Bio Announces Reverse Stock Split
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
18. April 2024 09:00 ET
|
Telesis Bio
Telesis Bio Inc. announces strategic focus on mRNA solutions and announces new leadership
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
28. März 2024 16:05 ET
|
Telesis Bio
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,...
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
26. Februar 2024 09:15 ET
|
Telesis Bio
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
Telesis Bio Reports Third Quarter 2023 Financial Results
13. November 2023 16:22 ET
|
Telesis Bio
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter...
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
07. November 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2023...